# ELUCIREM
> **NDA216986** · New Drug Application · Sponsor: GUERBET · Approved 2022-09-21
## Drug
- **FDA Application Number:** NDA216986
- **Application type:** New Drug Application
- **Brand name:** ELUCIREM
- **Generic name:** GADOPICLENOL
- **Active ingredients:** GADOPICLENOL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GUERBET
- **Manufacturer:** BRACCO DIAGNOSTICS INC
- **First approval:** 2022-09-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216986)
---
*AI Analytics · CC0 1.0*